Please login to the form below

Not currently logged in
Email:
Password:

Former Sanofi exec Joseph Devaney joins Astellas

He becomes government affairs and policy, Americas VP

Astellas Joseph DevaneyAstellas has appointed Joseph Devaney as vice president of government affairs and policy for its Americas business.

In this role, Devaney will be responsible for developing, communicating and implementing Astellas' federal and state government strategies in the US, as well as overseeing its engagement activities and policy development.

He joins the Japanese pharmaceutical firm from Sanofi, where he spent the last 20 years in a series of senior positions, including his most recent post as vice president of federal and state relations.

Prior to this, Devaney was director of state government affairs for Sandoz, which joined Novartis in 1996, and served as a research director and chief of staff for the New Jersey General Assembly.

Jeffrey Winton, senior vice president of corporate affairs at Astellas, said: “Joe's experience and leadership will elevate our highly collaborative team of senior government strategy, policy, legislative and regulatory professionals in Washington, DC.

“His role in developing Astellas' strategy on public policy issues being considered by government lawmakers and trade associations will be pivotal in Astellas' growth throughout the Americas.”

13th July 2016

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics